Edition:
India

INC Research Holdings Inc (INCR.OQ)

INCR.OQ on NASDAQ Stock Exchange Global Select Market

41.25USD
2:16am IST
Change (% chg)

$-0.60 (-1.43%)
Prev Close
$41.85
Open
$42.00
Day's High
$42.80
Day's Low
$41.20
Volume
347,769
Avg. Vol
267,998
52-wk High
$61.05
52-wk Low
$33.65

Chart for

About

INC Research Holdings, Inc. is a global contract research organization (CRO). The Company focuses on Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. The Company operates through two segments: Clinical Development Services and Phase I Services. The Company's Clinical... (more)

Overall

Beta: --
Market Cap(Mil.): $5,637.00
Shares Outstanding(Mil.): 103.53
Dividend: --
Yield (%): --

Financials

BRIEF-Inc Research Holdings qtrly GAAP diluted loss per share of $1.70‍​

* Inc Research Holdings - Net service revenue for the three months ended September 30, 2017 increased by $332.7 million, or 128.2%, to $592.2 million‍​

09 Nov 2017

BRIEF-INC Research Holdings Inc says on August 1, 2017, co entered into credit agreement

* INC Research Holdings Inc says on August 1, 2017, Inc Research Holdings, Inc entered into credit agreement - SEC filing

01 Aug 2017

EQT to acquire pharmaceutical services firm Certara

Private equity firm EQT said on Tuesday it has agreed to acquire U.S. drug development consultancy Certara for $850 million, including debt, from Arsenal Capital Partners, another buyout firm.

11 Jul 2017

UPDATE 1-EQT to acquire pharmaceutical services firm Certara

July 11 Private equity firm EQT said on Tuesday it has agreed to acquire U.S. drug development consultancy Certara for $850 million, including debt, from Arsenal Capital Partners, another buyout firm.

11 Jul 2017

Earnings vs. Estimates